We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Eden Research Plc | LSE:EDEN | London | Ordinary Share | GB0001646941 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.25 | 4.00 | 4.50 | 4.25 | 4.25 | 4.25 | 255,065 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 1.83M | -2.24M | -0.0042 | -10.12 | 22.67M |
Date | Subject | Author | Discuss |
---|---|---|---|
02/10/2021 20:25 | spadeychops 1 Oct '21 - 16:14 - 10709 > Who is Jo? You assiduously read these bordering-on-c RNSs and you don't know who Jo is, FFS. It is the creature paid to ramp and lie about this diseased cancer-ridden dog. Got it? spadeychops 2 Oct '21 - 08:11 - 10715 > when it does get back to that price" The epitaph of the AIM investor. ;D "when it does get back to that price" #idiot-living-in-hop #faith-is-believing- #tuckfard "when it does get back to that price" R . . . . . . . O . . . . . . . . . . . . T . . . . . . . . . . . . . . . F . . . . . . . . . . . . . . . . . L . . . . . . . . . . . . . . . . . . ! . . . . . . . . . . . . . . . . . . ! | neutralpov | |
01/10/2021 20:04 | spadeychops 1 Oct '21 - 16:46 - 10712 > when EDEN share price climbs upto and past 20p and well beyond Errrr, except that the share price has just been there to (just) beyond 20p in a carefully contrived ramp 'n pump which allowed those "in the know", mates of optionholders too, to dump and exit leaving complete fools like you holding. Came crashing down to 8p. :D Or didn't you notice, bungapoop? | neutralpov | |
01/10/2021 16:42 | Jo's posted sources which are the mangy pariah's only miserable fabrications don't count as sources or even sauces, you absolute cretin! And hehehe it's going to be really amusing on that inevitable day - intelligent opinion differs only on the when - that it goes belly-up. Will loudmouthed tuckfard fatchops just quietly fade into oblivion, like most of these doubledigiter coprophiliacs do, or will it start howling at the moon, thirsting for BoD BluD (or blaming its betters, the naysayers, who called a spadey a spadey, for der untergang?) (popcorn, chuckle @maroons) | neutralpov | |
01/10/2021 15:47 | Chrischas "if the board were in the slightest bit interested in the shareholders they would have said they had forthcoming ,encouraging sales of Mevalone ,in this last wet period across N Europe" They can only say what is. Are Mevalone sales encouraging in this last period across N Europe? I don't know, do you? In my opinion, Mevalone will be a portfolio product that will ultimately fund operations, whereas Sustaine sales aiding seed improvements will be a shareholder value driver. We are on the cusp of that as already RNS'd. It appears we will soon be due an update on our insecticide as well Source:hxxps://polar These are the imminent value drivers for shareholders. I get your share value disappointment, me too, but this is where we will make our shareholder money. In my opinion, try not to focus on Mevalone. | investingisatrickygame | |
30/9/2021 17:02 | Well if the board were in the slightest bit interested in the shareholders they would have said they had forthcoming ,encouraging sales of Mevalone ,in this last wet period across N Europe. They havent because they are incompetent and not really bothered. Sales are not on their agenda . The board are the ones solely responsible for the lack of sales during COVID. Agriculture/Horticul | chrischas | |
30/9/2021 15:07 | 'Nor have not asked for cash', double negative chops. | ravenna23 | |
30/9/2021 14:45 | Cash will run out in 18 months. It will be in management pockets. Yes the story is inspirational, unfortunately the reality is dire. | ravenna23 | |
30/9/2021 13:21 | So the IP has value? | timbo_slice | |
30/9/2021 13:03 | As money runs out (no sales, no dosh) there'll be more dilution, both via new stock issue and new loans and bonds issued (likely including some to mates) The bondholders will end up with the lot, and in the phoenix, the IP will be ""sold"" (given away, more like) to a newco. Guess who will control that one. ;D Simple as pie. Piece of cake. Seen it 100s of times before. EDEN is a hAOx. GedIDt? Or is that too complex for the doublets? (rofl, popcorn) | neutralpov | |
30/9/2021 12:58 | Fast forward a year or two. She'll be thirsting and baying for the blurd of those who hoaxed her. Start with the last RNS for names - it's more than direct employees of the corp(se). Thirsting and baying in vain, for they've stayed just about within what the law requires. | neutralpov | |
30/9/2021 12:04 | Chops, please inform me, what exactly is misleading content in my last two posts? You are either deluded or dishonest, which is it? Clearly you are happy to give your money to the board. I am sure they appreciate your generosity. | ravenna23 | |
30/9/2021 11:27 | Further to my previous post, the action that led to the re-rating of the share earlier this year, namely admission to the green index, in all probability has little to do with the efforts of the CEO or CFO, probably due to the company stockbroker. However executives have blown this away with the FRC investigation. All gains have been lost, doubtless the green funds that have been burnt will avoid Eden in future. Mud sticks. | ravenna23 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions